Answers are grounded in this paper and cite their sources.
The purpose of this perspective is to indicate the range of chemistries used in the manufacture of drug candidate molecules and to highlight certain gaps in current technologies. To do this a survey was carried out of chemical syntheses within the Process Chemistry R&D departments of GlaxoSmithKline, AstraZeneca and Pfizer.
No takes yet. Share an insight, caveat, or question.
Carey et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: